HealthyDirect · GrowthFit for a long SIP
Edelweiss Arbitrage Fund
Edelweiss Mutual FundHybrid Scheme - Arbitrage Fund12.3 years
- NAV
- 22.5892
- 29 Oct 2026
- 1Y
- +6.6%
- Trailing CAGR
- AUM
- ₹14,250.16 Cr
- 30 Sept 2026
- Volatility
- Low
- 1.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Pass
12.3 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Watch
1.53% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -0.5%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 101.9% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 1%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+6.6%
- 3Y+7.3%
- 5Y+6.9%
- 10Y+6.5%
- SI+6.8%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+6.3%
- 3Y+6.9%
- 5Y+7.1%
- 10Y+6.6%
- Since inception
- +6.8%
- Calendar-day CAGR
- Excess 1Y
- -0.0%
- Category median, same plan and option
- 3Y win rate
- +100%
- Windows beating the median
- 3Y percentile
- 79
- Vs comparable share classes
- SIP 3Y XIRR
- +6.9%
- Simulated monthly SIP
- Worst rolling 3Y
- +4.8%
- 2302 daily-ending windows
- Median rolling 3Y
- +6.8%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 1809 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -0.5%
- Worst peak-to-trough
- Current
- -0.2%
- Below last peak
- Current spell
- 6 days
- Days below latest peak
- Time below peak
- +44%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 2 days
- 684 recovered episodes
- Longest recovery
- 72 days
- Trough to prior peak
29 May 2020 – 14 Aug 2020
Trough 3 Jun 2020 · recovered in 72 days
-0.5%
3 Aug 2026 – 24 Aug 2026
Trough 6 Aug 2026 · recovered in 18 days
-0.4%
24 Aug 2026 – 1 Sept 2026
Trough 26 Aug 2026 · recovered in 6 days
-0.3%
16 Mar 2020 – 27 Mar 2020
Trough 25 Mar 2020 · recovered in 2 days
-0.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
79
Vs category
50
Consistency
99
Risk-adjusted
66
Drawdown
99
Mean
79
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 194 holdings · top 10 are 101.9%.
- Top 5
- 91.9%
- Top 10
- 101.9%
- Largest holding
- 69.5%
- Effective holdings
- 2.0
Cash Margin
Unspecified
69.5%
Edelweiss Liquid Direct-Growth
Unspecified
7.9%
ICICI Bank Ltd
Financial
5.4%
HDFC Bank Ltd
Financial
5.0%
Edelweiss Bond Fund Direct-Growth
Unspecified
4.1%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
quant Arbitrage Fund
quant Mutual Fund
- 1Y
- +7.5%
- 3Y
- n/a
- Vol
- 1.3%
- Max DD
- -0.4%
- Sharpe
- 0.96
- 3Y win
- n/a
- Shallower drawdown
- Higher trailing returns
Caveat: Higher volatility · Higher TER
ADITYA BIRLA SUN LIFE ARBITRAGE FUND
Aditya Birla Sun Life Mutual Fund
- 1Y
- +6.6%
- 3Y
- +7.3%
- Vol
- 1.1%
- Max DD
- -0.5%
- Sharpe
- 0.89
- 3Y win
- +56%
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Bajaj Finserv Arbitrage Fund
Bajaj Finserv Mutual Fund
- 1Y
- +6.4%
- 3Y
- +6.9%
- Vol
- 1.1%
- Max DD
- -0.4%
- Sharpe
- 0.87
- 3Y win
- 0%
- Shallower drawdown
- Lower TER
Caveat: Higher volatility · Lower trailing returns
BARODA BNP PARIBAS ARBITRAGE FUND
Baroda BNP Paribas Mutual Fund
- 1Y
- +6.2%
- 3Y
- +7.2%
- Vol
- 1.0%
- Max DD
- -0.3%
- Sharpe
- 0.82
- 3Y win
- +65%
- Shallower drawdown
- Lower TER
Caveat: Higher volatility · Lower trailing returns
Franklin India Arbitrage Fund
Franklin Templeton Mutual Fund
- 1Y
- +6.9%
- 3Y
- n/a
- Vol
- 1.2%
- Max DD
- -0.4%
- Sharpe
- 0.80
- 3Y win
- n/a
- Shallower drawdown
- Lower TER
Caveat: Higher volatility · Lower trailing returns